2021 Agenda

DAY 1 – SYMPOSIUM

Friday, October 8, 2021

OPENS AT 12:00PM • PDT (UTC-7)

DAY 2 – SYMPOSIUM

Saturday, October 9, 2021

OPENS AT 8:OOAM • PDT (UTC-7)

Agenda Day 2 • Saturday, October 9, 2021

8:00 AM • VENUE OPENS • PDT (UTC-7)

For all attendees: Pre-event networking with TOBI exhibitors and attendees.

8:30 AM • WELCOME

Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

TOBI Networks Introduction

Rikin Patel, MD, CEO, TOBI Conference and TOBI Networks

8:40 AM • Bone Marrow Concentrate (BMC)

Role of Scaffolds, Subchondral, Intra-articular Injections of BMC: Different Approaches & Different Results

Phillippe Hernigou, MD, Henri-Mondor University Hospital, Paris, France

Bone Marrow Concentrate in the Treatment of Knee Osteoarthritis: 5 Year Outcomes Data

Kristin Oliver, MD, MPH, Blue Tail Medical Group, Chesterfield, MO

Bone Marrow Expanded MSC's Vs LP-PRP in Chronic Patellar Tendinopathy: Prelimenary Outcomes with Ultrasound, UTC, and MRI Imaging

Nicola Maffulli, MD, MS, PhD, FRCP, FRCS, Queen Mary University of London, London, United Kingdom

Comparison of Traditional vs New BMA Harvest Needles

Gregory Lutz, MD, Regenerative Sports Institute, New York, NY

Safety and Efficacy of Bone Marrow Concentrate and Platelet Rich Plasma for Posttraumatic Arthritis of the Ankle: A Retrospective Case Series

Henry Stiene, MD, Beacon Orthopaedics & Sports Medicine, Cincinnati, OH

Ask the Experts: Live BMC Panel Discussion with Q&A

Kristin Oliver, MD, MPH, Blue Tail Medical Group, Chesterfield, MO
Greg Lutz, MD, Regenerative Sports Instiute, New York, NY
Don Buford, MD, Dallas PRP and Stem Cell Institute, Dallas, TX
David Karli, MD, Greyledge Technologies, Steadman Clinic, Vail, CO
Sean Mulvaney, MD, Regenerative Orthopedics & Sports Medicine (ROSM), Annapolis, MD
MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

9:45 AM • ADIPOSE

Two-year Outcomes of Autologous Microfragmented Adipose Tissue (MFAT) in Elderly Patients with Knee Osteoarthritis: A Multi-Centric, International Study

Alberto Gobbi, MD, O.A.S.I Bioresearch Foundation Gobbi NPO, Milan, Italy

A 12-Month Cohort Study to Investigate Changes in Patient-Reported Outcomes after Intra-Articular Injection of Micro-Fragmented Adipose Tissue for Knee Osteoarthritis

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Adipose Harvest: Interventional Orthobiologic Foundation (IOF) Optimal Technique Demonstration

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Safety Meets Innovation in Regenerative Medicine

Tiffany Facile MHA, RN, Regenerative Medicine at Sanford Health, Sioux Falls, SD

Prospective Clinical Comparison Between LP-PRP Combined with HA and Autologous Microfragmented Adipose Tissue in Early Knee Osteoarthritis

Ignacio Dallo, MD, O.A.S.I. Bioresearch Foundation Gobbi NPO, Milan, Italy

Novel Technique: Adipose Stem Cells From Knee Liposuction For Knee Osteoarthritis

Dimitrios Tsoukas, MD, MSc, HYGEIA Hospital, Athens, Greece

Live Ask the Experts: Adipose Panel Discussion with Q&A

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Christopher Rogers, MD, San Diego Orthobiologics Medical Group, Carlsbad, CA

Brian Shiple, DO, RMSK, The Center for Sports Medicine, Springfield, PA

Joanne Borg-Stein, MD, Harvard Medical School, Cambridge, MA

Randy Miller, MD, Cosmetic & Reconstructive Surgery, Coconut Grove, FL

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

10:45 AM • BREAK  (Non-CME)

An inside look: how a medical device company can help you deliver biomaterials more efficient & effectively.

Trent Hagen, Product Line Manager, Biomaterial Delivery Expert, Nordson Medical

Sponsored by Nordson Medical

Impact of Osteoarthritis in the Military

Kenneth L. Cameron, PhD, MPH, ATC

Sponsored by Terumo BCT

11:20 AM • REGULATORY & CLINICAL SUPPORT

Ten Takeaways in Ten Minutes for the Twelfth TOBI

Andrew Ittleman, Esq., Fuerst Ittleman David & Joseph, Miami, FL

Injectable Amniotic Tissue Allograft As A Regulated Biologic: The Path Forward

Carl Flannery, PhD, Bioventus, Durham, NC

Regenerative Medicine: The 21st Century Cures Act And Changing Dynamics

Laxmaiah Manchikanti, MD, Chairman of the Board and Chief Executive Officer, ASIPP and SIPMS, Co-Founder and Director, Pain Management Centers of America, Paducah, KY

Live Regulatory Townhall: What Can & Can't I Do?

Scott Bruder, MD, PhD, Bruder Consulting & Venture Group, New York, NY

Don Buford, MD, RMSK, Dallas PRP and Stem Cell Institute, Dallas, TX

Andrew Ittleman, Esq., CAMS, Fuerst Ittleman David & Joseph, Miami, FL

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

Live Post Pandemic Practice Growth Strategies: Leading Clinicians Trade Notes

Jay Bowen, DO, New Jersey Sports Medicine, Cedar Knolls, NJ

John Ferrell, MD, Regenerative Orthopedics and Sports Medicine, Annapolis, MD

Paul Tortland, DO, FAOASM, RMSK, Valley Sports Physicians and Orthopedic Medicine, Glastonbury, CT

Rahul Desai, MD, RestorePDX, Beaverton, OR

Annu Navani, MD, ABIPP, DABRM, FAARM, Comprehensive Spine and Sports Center, Campbell, CA

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

12:20 PM • LUNCH BREAK  (Non-CME)

Signature Cord Prime™ - FDA Approved Investigational New Drug hUC Tissue for Knee OA Study: Discussion on Preclinical Data & Mechanisms of Action

Jonathan Hernandez, PhD, Vice President of Research and Development, Dallas, TX
Dan Wagner,
Vice President of Sales, Marketing, and Business Development, Dallas, TX

PRP/BMC Standardization exists, Biotech R & D Demonstration

Antoine Turzi, RegenLab CEO & Michael Tucker, MD

1:20 PM • SPORTS MEDICINE & SURGICAL BIOLOGICS

Orthobiologics of the Knee in the Professional Soccer Athlete: Current Practice and Trends

Ramon Cugat, MD, PhD Garcia Cugat Foundation, Barcelona, Spain

Tokyo 2021 Venue Ultrasound Program

Kentaro Onishi, MD, University of Pittsburgh Medical Center, Pittsburgh, PA

Bridging the Gap Between Surgical and Conservative Treatment: The SUBA Protocol: (Sports, Ultrasound, Biologics, Arthroscopy)

Pedro Bernaldez, MD, PhD, SportMe Sports Traumatology, Seville, Spain

ACL Allograft Reconstruction Augmented with Bone Marrow Aspirate Concentrate: Does It Help? A Randomized Clinical Trial

Jorge Chahla, MD, PhD, Rush University Medical Center, Chicago, IL

Mini-Battle. Treatment of Meniscus Tears: Surgery vs Injection?

Bert Mandelbaum, MD, Cedars-Sinai Kerlan-Jobe Institute, Los Angeles, CA

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

Live Team Physician Roundtable: Orthobiologics in the Professional Athlete

Ken Mautner, MD, Head Team Physician: Atlanta Hawks and Atlanta Braves
Kristofer Jones, MD, Head Team Physician: Los Angeles Lakers and UCLA Bruins Men’s Basketball
Chad Hanson, MD, Head Team Physician Las Vegas Raiders and Team Physician Vegas Golden Knights
Riley Williams, Head Team Physician Brooklyn Nets and New York Red Bulls
MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

2:30 PM • WHAT'S NEW

The Details Are In The Data: Early Findings from Patient Outcome Registry Data of Orthobiologic Treatments

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Orthobiologics in the United States Military: Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR)

Jenny Yuan MD, PhD, Uniformed Services University of the Health Sciences, Bethesda, MD

Clinical and Biochemical Outcomes of Anabolic Joint Injections

Kevin Stone, MD,Orthopaedic Surgeon, The Stone Clinic, San Francisco, CA

Autologous Conditioned Serum (ACS) in the Treatment of Orthopedic Disease: a Personalized Approach in Regenerative Pain Therapy

Peter Wehling, MD, PhD, Dr. Wehling & Partner, Düsseldorf, Germany

Comparison of Umbilical Cord Tissue, Bone Marrow Concentrate, Adipose SVF, and Cortosteroid Injections for knee Osteoarthritis: Multicenter Study Design and Early Data

Ken Mautner, MD, Emory University, Atlanta, GA

The Next Generation of Platelet Rich Plasma Injections

Adeel Khan, MD, Institute of Human Mechanics, Toronto, Canada

Conditioned Autologous Serum (CAS): Evidence in Knee Osteoarthritis

William "Bill" Murrell, MD, MS, Plancher Orthopaedics and Sports Medicine, New York, NY

Ask the Experts: Live Panel Discussion on What’s New with Q&A

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Adeel Khan, MD, Institute of Human Mechanics, Toronto, Canada

Ken Mautner, MD, Emory University, Atlanta, GA

Bill Murrell, MD, MS, Emirates Integra Medical & Surgery Centre, Dubai, UAE

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

3:55 PM • INNOVATION TALK  (Non-CME)

Evaluation of the Safety and Exploratory Efficacy of an Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis: An FDA/IND Approved Phase 1/2a Clinical Trial

Christoper Rogers, MD, PM, San Diego Orthobiologics Medical Group, Carlsbad, CA

4:30 PM • IO/SUBCHONDRAL BONE

Subchondral and Intra-articular Injections of Bone Marrow Concentrate are a Safe and Effective Treatment for Knee Osteoarthritis: A Prospective, Multi-center Pilot Study

Elizaveta Kon, MD, Humanitas University and Humanitas Research and Teaching Hospital, Milan, Italy

Does Low Volume IO BMC Injection into BMLs Work? A Matched Cohort Comparison

Christopher Centeno, MD, Centeno-Schultz Clinic, Broomfield, CO

Intraosseous Injections of PRP in an Office Setting Without Anesthesia: (IOLA) A Disruptive Technique

Antonio Rios-Luna, MD, PhD, Especialista en Traumatología y Cirugía Ortopédica

Dysbiosis: Microbiome Influence on Intervertebral and Degenerative Disc Disease

Marin Jerome, MD, Regenerative SportsCare Institute, New York, NY

Ask the Experts: Live IO/Subchondral Bone Panel Discussion with Q&A

Christopher Centeno, MD, Centeno-Schultz Clinic, Broomfield, CO

Marin Jerome, MD, Regenerative SportsCare Institute, New York, NY

Brice Blatz, MD, RestorePDX, Beaverton, OR

Chris Williams, MD, Interventional Orthopedics of Atlanta, Atlanta, GA

MOD: Rowan V. Paul, Inc | RegenCore Method, San Francisco, CA

5:25 PM • SUMMARY & CLOSING REMARKS  (Non-CME)

Summary: TOBI 2021 Takeaways and Protocols

Nicholas Beatty, DO, RMSK, Mount Sanai, New York, NY

Closing Comments

Steven Sampson, DO, TOBI (The Orthobiologic Institute), Los Angeles, CA

GO TO

DAY 1 – SYMPOSIUM

Friday, October 8, 2021

OPENS AT 12:00PM • PDT (UTC-7)

DAY 1 – SYMPOSIUM

Friday, October 8, 2021

OPENS AT 12:00PM • PDT (UTC-7)

DAY 2 – SYMPOSIUM

Saturday, October 9, 2021

OPENS AT 8:OOAM • PDT (UTC-7)

Agenda Day 2
Saturday, October 9, 2021

8:00 AM • VENUE OPENS

For all attendees: Pre-event networking with TOBI exhibitors and attendees.

8:30 AM • WELCOME

Rowan V. Paul MD, Inc | RegenCore Method, San Francisco, CA

TOBI Networks Introduction

Rikin Patel, MD, CEO, TOBI Conference and TOBI Networks

8:40 AM • Bone Marrow Concentrate (BMC)

Role of Scaffolds, Subchondral, Intra-articular Injections of BMC: Different Approaches & Different Results

Phillippe Hernigou, MD, Henri-Mondor University Hospital, Paris, France

Bone Marrow Concentrate in the Treatment of Knee Osteoarthritis: 5 Year Outcomes Data

Kristin Oliver, MD, MPH, Blue Tail Medical Group, Chesterfield, MO

Bone Marrow Expanded MSC's Vs LP-PRP in Chronic Patellar Tendinopathy: Prelimenary Outcomes with Ultrasound, UTC, and MRI Imaging

Nicola Maffulli, MD, MS, PhD, FRCP, FRCS, Queen Mary University of London, London, United Kingdom

Comparison of Traditional vs New BMA Harvest Needles

Gregory Lutz, MD, Regenerative Sports Institute, New York, NY

Safety and Efficacy of Bone Marrow Concentrate and Platelet Rich Plasma for Posttraumatic Arthritis of the Ankle: A Retrospective Case Series

Henry Stiene, MD, Beacon Orthopaedics & Sports Medicine, Cincinnati, OH

Ask the Experts: Live BMC Panel Discussion with Q&A

Kristin Oliver, MD, MPH, Blue Tail Medical Group, Chesterfield, MO
Greg Lutz, MD, Regenerative Sports Instiute, New York, NY
Don Buford, MD, Dallas PRP and Stem Cell Institute, Dallas, TX
David Karli, MD, Greyledge Technologies, Steadman Clinic, Vail, CO
Sean Mulvaney, MD, Regenerative Orthopedics & Sports Medicine (ROSM), Annapolis, MD
MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

9:45 AM • ADIPOSE

Two-year Outcomes of Autologous Microfragmented Adipose Tissue (MFAT) in Elderly Patients with Knee Osteoarthritis: A Multi-Centric, International Study

Alberto Gobbi, MD, International Cartilage Repair Society

A 12-Month Cohort Study to Investigate Changes in Patient-Reported Outcomes after Intra-Articular Injection of Micro-Fragmented Adipose Tissue for Knee Osteoarthritis

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Adipose Harvest: Interventional Orthobiologic Foundation (IOF) Optimal Technique Demonstration

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Safety Meets Innovation in Regenerative Medicine

Tiffany Facile MHA, RN, Regenerative Medicine at Sanford Health, Sioux Falls, SD

Prospective Clinical Comparison Between LP-PRP Combined with HA and Autologous Microfragmented Adipose Tissue in Early Knee Osteoarthritis

Ignacio Dallo, MD, O.A.S.I. Bioresearch Foundation Gobbi NPO, Milan, Italy

Novel Technique: Adipose Stem Cells From Knee Liposuction For Knee Osteoarthritis

Dimitrios Tsoukas, MD, MSc, HYGEIA Hospital, Athens, Greece

Live Ask the Experts: Adipose Panel Discussion with Q&A

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Christopher Rogers, MD, San Diego Orthobiologics Medical Group, Carlsbad, CA

Brian Shiple, DO, RMSK, The Center for Sports Medicine, Springfield, PA

Joanne Borg-Stein, MD, Harvard Medical School, Cambridge, MA

Randy Miller, MD, Cosmetic & Reconstructive Surgery, Coconut Grove, FL

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

10:45 AM • BREAK  (Non-CME)

An inside look: how a medical device company can help you deliver biomaterials more efficient & effectively.

Trent Hagen, Product Line Manager, Biomaterial Delivery Expert, Nordson Medical

Sponsored by Nordson Medical

Impact of Osteoarthritis in the Military

Kenneth L. Cameron, PhD, MPH, ATC

Sponsored by Terumo BCT

11:20 AM • REGULATORY & CLINICAL SUPPORT

Ten Takeaways in Ten Minutes for the Twelfth TOBI

Andrew Ittleman, Esq., Fuerst Ittleman David & Joseph, Miami, FL

Injectable Amniotic Tissue Allograft As A Regulated Biologic: The Path Forward

Carl Flannery, PhD, Bioventus, Durham, NC

Regenerative Medicine: The 21st Century Cures Act And Changing Dynamics

Laxmaiah Manchikanti, MD, Chairman of the Board and Chief Executive Officer, ASIPP and SIPMS, Co-Founder and Director, Pain Management Centers of America, Paducah, KY

Live Regulatory Townhall: What Can & Can't I Do?

Scott Bruder, MD, PhD, Bruder Consulting International, New York, NY

Don Buford, MD, RMSK, Dallas PRP and Stem Cell Institute, Dallas, TX

Andrew Ittleman, Esq., CAMS, Fuerst Ittleman David & Joseph, Miami, FL

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

Live Post Pandemic Practice Growth Strategies: Leading Clinicians Trade Notes

Jay Bowen, DO, New Jersey Sports Medicine, Cedar Knolls, NJ

John Ferrell, MD, Regenerative Orthopedics and Sports Medicine, Annapolis, MD

Paul Tortland, DO, FAOASM, RMSK, Valley Sports Physicians and Orthopedic Medicine, Glastonbury, CT

Rahul Desai, MD, RestorePDX, Beaverton, OR

Annu Navani, MD, MD, ABIPP, DABRM, FAARM, Comprehensive Spine and Sports Center, Campbell, CA

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

12:20 PM • LUNCH BREAK  (Non-CME)

Signature Cord Prime™ - FDA Approved Investigational New Drug hUC Tissue for Knee OA Study: Discussion on Preclinical Data & Mechanisms of Action

Jonathan Hernandez, PhD, Vice President of Research and Development, Dallas, TX
Dan Wagner,
Vice President of Sales, Marketing, and Business Development, Dallas, TX

PRP/BMC Standardization exists, Biotech R & D Demonstration

Antoine Turzi, RegenLab CEO & Michael Tucker, MD

1:20 PM • SPORTS MEDICINE & SURGICAL BIOLOGICS

Orthobiologics of the Knee in the Professional Soccer Athlete: Current Practice and Trends

Ramon Cugat, MD, PhD Garcia Cugat Foundation, Barcelona, Spain

Tokyo 2021 Venue Ultrasound Program

Kentaro Onishi, MD, University of Pittsburgh Medical Center, Pittsburgh, PA

Bridging the Gap Between Surgical and Conservative Treatment: The SUBA Protocol: (Sports, Ultrasound, Biologics, Arthroscopy)

Pedro Bernaldez, MD, PhD, SportMe Sports Traumatology, Seville, Spain

ACL Allograft Reconstruction Augmented with Bone Marrow Aspirate Concentrate: Does It Help? A Randomized Clinical Trial

Jorge Chahla, MD, PhD, Rush University Medical Center, Chicago, IL

Mini-Battle. Treatment of Meniscus Tears: Surgery vs Injection?

Bert Mandelbaum, MD, Cedars-Sinai Kerlan-Jobe Institute, Los Angeles, CA

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

MOD: Rowan Paul, MD, California Pacific Orthopedics, San Francisco, CA

Live Team Physician Roundtable: Orthobiologics in the Professional Athlete

Ken Mautner, MD, Head Team Physician: Atlanta Hawks and Atlanta Braves
Kristofer Jones, MD, Head Team Physician: Los Angeles Lakers and UCLA Bruins Men’s Basketball
Chad Hanson, MD, Head Team Physician Las Vegas Raiders and Team Physician Vegas Golden Knights
Riley Williams, Head Team Physician Brooklyn Nets and New York Red Bulls
MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

2:30 PM • WHAT'S NEW

The Details Are In The Data: Early Findings from Patient Outcome Registry Data of Orthobiologic Treatments

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Orthobiologics in the United States Military: Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR)

Jenny Yuan, MD, PhD, Uniformed Services University of the Health Sciences, Bethesda, MD

Clinical Outcomes of Anabolic Joint Injections with HA, PRP and Amniotic Fluid

Kevin Stone, MD,Orthopaedic Surgeon, The Stone Clinic, San Francisco, CA

Autologous Conditioned Serum (ACS) in the Treatment of Orthopedic Disease: a Personalized Approach in Regenerative Pain Therapy

Peter Wehling, MD, PhD, Dr. Wehling & Partner, Düsseldorf, Germany

IRAP injections For Degenerative Joint Disease

TBD

Comparison of Umbilical Cord Tissue, Bone Marrow Concentrate, Adipose SVF, and Cortosteroid Injections for knee Osteoarthritis: Multicenter Study Design and Early Data

Ken Mautner, MD, Emory University, Atlanta, GA

The Next Generation of Platelet Rich Plasma Injections

Adeel Khan, MD, Institute of Human Mechanics, Toronto, Canada

Conditioned Autologous Serum (CAS): Evidence in Knee Osteoarthritis

William "Bill" Murrell, MD, MS, Plancher Orthopaedics and Sports Medicine, New York, NY

Ask the Experts: Live Panel Discussion on What’s New with Q&A

Gerard Malanga, MD, New Jersey Sports Medicine, Cedar Knolls, NJ

Adeel Khan, MD, Institute of Human Mechanics, Toronto, Canada

Ken Mautner, MD, Emory University, Atlanta, GA

Bill Murrell, MD, Emirates Integra Medical & Surgery Centre, Dubai, UAE

MOD: Rowan V. Paul, MD, Inc | RegenCore Method, San Francisco, CA

4:00 PM • INNOVATION TALK  (Non-CME)

Evaluation of the Safety and Exploratory Efficacy of an Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis: An FDA/IND Approved Phase 1/2a Clinical Trial

Christoper Rogers, MD, PM,San Diego Orthobiologics Medical Group, Carlsbad, CA

4:30 PM • IO/SUBCHONDRAL BONE

Subchondral and Intra-articular Injections of Bone Marrow Concentrate are a Safe and Effective Treatment for Knee Osteoarthritis: A Prospective, Multi-center Pilot Study

Elizaveta Kon, MD, Humanitas University and Humanitas Research and Teaching Hospital, Milan, Italy

Does Low Volume IO BMC Injection into BMLs Work? A Matched Cohort Comparison

Christopher Centeno, MD, Centeno-Schultz Clinic, Broomfield, CO

Intraosseous Injections of PRP in an Office Setting Without Local Anesthesia: (IOLA) A Disruptive Technique

Antonio Rios-Luna, MD, Phd, Especialista en Traumatología y Cirugía Ortopédica

Dysbiosis: Microbiome Influence on Intervertebral and Degenerative Disc Disease

Marin Jerome, MD, Regenerative SportsCare Institute, New York, NY

Ask the Experts: Live IO/Subchondral Bone Panel Discussion with Q&A

Christopher Centeno, MD, Centeno-Schultz Clinic, Broomfield, CO

Marin Jerome, MD, Regenerative SportsCare Institute, New York, NY

Brice Blatz, MD, RestorePDX, Beaverton, OR

Chris Williams, MD, Interventional Orthopedics of Atlanta, Atlanta, GA

MOD: Rowan V. Paul, Inc | RegenCore Method, San Francisco, CA

5:25 PM • SUMMARY & CLOSING REMARKS  (Non-CME)

Summary: TOBI 2021 Takeaways and Protocols

Nicholas Beatty, DO, RMSK, Mount Sanai, New York, NY

Closing Comments

Steven Sampson, DO, TOBI (The Orthobiologic Institute), Los Angeles, CA

GO TO

DAY 1 – SYMPOSIUM

Friday, October 8, 2021

OPENS AT 12:00PM • PDT (UTC-7)